Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Iran says U.S. approved its funds transfer to buy COVID vaccines

Published 12/24/2020, 01:59 PM
Updated 12/24/2020, 02:56 PM
© Reuters. Patients suffering from the coronavirus disease (COVID-19), lie in beds at an intensive care unit at a hospital in Tehran

DUBAI (Reuters) -Iran has won U.S. approval to transfer funds for coronavirus vaccines from overseas, the central bank chief said on Thursday, as its daily death toll fell to a three-month low.

Central Bank governor Abdolnaser Hemmati said an Iranian bank had received backing from the U.S. Treasury's Office of Foreign Assets Control to transfer the money to a Swiss bank to pay for the vaccines.

"They (Americans) have put sanctions on all our banks. They accepted this one case under the pressure of world public opinion," Hemmati told state TV.

There was no immediate U.S. reaction to Hemmati's remarks.

Hemmati said Iran would pay around $244 million for initial imports of 16.8 million doses of vaccines from COVAX, a multi-agency group dedicated to assuring fair access to vaccines for low- and middle-income countries.

Iranian officials have said repeatedly that U.S. sanctions are preventing them from making payments to COVAX, to which some 190 economies have signed up.

Iran's Shifa Pharmed began registering volunteers this week for human trials of the country's first domestic COVID-19 vaccine candidate, Iranian media reported, as a factional dispute appeared to be brewing over the use of imports.

"We do not recommend injecting foreign coronavirus vaccines to the personnel of the Revolutionary Guards and the basij (voluntary militia)," Iranian news outlets quoted Mohammed Reza Naqdi, a deputy head of the hardline Guards, as saying.

Health Ministry spokeswoman Sima Sadat Lari told state TV earlier that 152 people had died of COVID-19 in Iran in the past 24 hours, the lowest number since Sept. 18, taking total deaths to 54,308 in the worst-affected country in the Middle East.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The fall in deaths comes after more than a month of night traffic curfews and other restrictions in major cities. Police said 96,000 fines were issued nationwide on Wednesday for drivers breaking the curfew.

Officials have cautioned that the danger of a resurgence in infections looms large.

U.S. President Donald Trump pulled out of the 2015 nuclear deal between Iran and six world powers in 2018 and imposed new sanctions on the country.

President-elect Joe Biden's coming to power has raised the possibility that Washington could rejoin the agreement.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.